perianal

(redirected from perianal warts)
Also found in: Dictionary, Medical.
Related to perianal warts: Anogenital warts

perianal

[¦per·ē′ān·əl]
(anatomy)
Situated or occurring around the anus.
References in periodicals archive ?
In two Phase III randomized, double-blind, vehicle-controlled studies, Veregen(TM) proved effective in clearing both baseline and newly emerging external genital and perianal warts, with complete clearance in 53.
The safety and efficacy of Veregen(TM) in immunosuppressed patients, in the treatment of external genital and perianal warts beyond 16-weeks, or for multiple treatment courses have not been established.
Aldara Cream is indicated for actinic keratosis, superficial basal cell carcinoma, and external genital and perianal warts.
Pursuant to our agreement for VEREGEN(TM), we have been granted the exclusive license, or sublicense in certain instances, to certain patents and other intellectual property for commercialization in the United States as a prescription product of any ointment or other topical formulation containing green tea catechins, a novel active ingredient, for the treatment of dermatological diseases in humans, including external genital warts, perianal warts and actinic keratosis.
The agent, approved in the United States for treatment of external genital and perianal warts, has a "rather complex method of action.
The approval of Elestrin(TM) follows the FDA approval in October 2006 of Polyphenon(R) E Ointment, 15%, a patent protected product in-licensed by Bradley for the treatment of external genital and perianal warts.
3M currently markets Aldara (imiquimod) Cream, 5%, the first topical IRM to be marketed globally, for the treatment of actinic keratosis, primary superficial basal cell carcinoma, and external genital and perianal warts.
Food and Drug Administration (FDA) to market Polyphenon E(R) Ointment, 15%, a new drug indicated for the treatment of external genital and perianal warts and patented through 2017.
Available by prescription only, Aldara cream is the only patient-applied cream approved by the FDA for the treatment of external genital and perianal warts.
Bradley's heightened presence in the OB/GYN market is an important step in preparing for the anticipated launch during 2007 by both Bradley's Kenwood Therapeutics division (to be targeted to the OB/GYN marketplace) and Doak Dermatologics subsidiary (to be targeted to the dermatology marketplace) of POLYPHENON(R) E Ointment, a topical treatment for external genital and perianal warts.
Aldara cream, currently the leading prescription treatment for external genital and perianal warts, is the first IRM application submitted for the sBCC indication.
The active ingredient in the ointment is patented for use as a prescription treatment for external genital and perianal warts.